Laurion Capital Management »

Cyteir Therapeutics shares owned by Laurion Capital Management

Quarter-by-quarter ownership of Cyteir Therapeutics shares owned by Laurion Capital Management from 13F filings

Historical chart of Laurion Capital Management investment in Cyteir Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cyteir Therapeutics held by Laurion Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cyteir Therapeutics by Laurion Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $961k 316k 3.04
2023-09-30 $1.0M 360k 2.84
2023-06-30 $935k 360k 2.60
2023-03-31 $654k 360k 1.82
2022-12-31 $593k 360k 1.65
2022-09-30 $690k 360k 1.92
2022-06-30 $1.1M 360k 2.99

More positions owned by Laurion Capital Management

Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
Meta Platforms Cl A Call Option (META)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
NVIDIA Corporation Call Option (NVDA)
Apple (AAPL)
Alibaba Group Hldg Sponsored Ads Call Option (BABA)
Broadcom Call Option (AVGO)
Ishares Tr Msci Eafe Etf (EFA)
Tesla Motors Call Option (TSLA)
Boeing Company (BA)
Alphabet Cap Stk Cl A (GOOGL)
Microsoft Corporation (MSFT)
Home Depot (HD)
JPMorgan Chase & Co. Call Option (JPM)
Adobe Systems Incorporated (ADBE)

View all positions for Laurion Capital Management

Top funds holding Cyteir Therapeutics

BML Capital Management
Acadian Asset Management
Boston Family Office
Lindbrook Capital

View all funds holding Cyteir Therapeutics